PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Registered number: 01635916 Charity number: 284881 PENNY BROHN CANCER CARE TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2024
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT CONTENTS PAGE Reference and Administrative Details of the Charity, its Trustees and Advisers Independent Auditor's Report on the Financial Statements 19 Consolidated Statement of Financial Activities 22 Charity Statement of Financial Activities 23 Charity and Consolidated Balance Sheet 24 Consolidated Statement of Cash Flows 25 Notes lo the Financial Statements 26
PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES ANDADVISERS Trustees Amanda Hill.,. Bina Shah 2&4 Bronwen Wright, (appointed 10.05.2024} Charles Russell-smilh Charlotte While (resigned 12.07.20241 Emma Wallis'°.' (appointed 10.05.20241 Harvey Marcus." . lappoinled 10.05.20241 Jacqueline Graves ' Jayne Tucker, Jessica Brohn Jonathan Green ' Kate Pavli Nicola Newton Stephen Rosser, ' {appointed 10.05.2024} 2È4 Sub<ommittees Finance and Audit Committee, 2. People, Culture and Inclusion Committee. 3. Commercial Committee 4. Services Committee 5. Fundraising and Marketing Committee Company Registered Number 01635916 Charlty Reglstered Number 284881 Registered Office Chapel Pill Lane, Pill, Bristol, BS20 OHH Company Secretary Lisa Day Iresigned 16.05.20251 Eleanor Davies {appoinled 16.05.20251 Chief Executive Officer Andrew Hufford Independent Auditors Burton Sweet Limited The Clock Tower 5 Farleigh Court Old Weston Road Flax Bourton Bristol BS48 1 UR "We need more than medicine to live well with cancer. We need to care for our mind, emotions. spirit, heart and soul." Penny Brohn. 1980
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Chair's Foreword It is my privilege lo introduce Penny Brohn Cancer Care's Annual Report for 2024.. a year shaped by renewed clarity, growing impact, and deepened commitment lo those we serve. Over the past year, Penny Brohn Cancer Care supported 4,989 individuals through our National Cenlre, online services, and partnership with Genesiscare. Of ihese, 2,137 accessed our in-person and online ServIS directly la 9°/0 increase on the previous yearl and we saw a 30 /0 rise in new client registrations. This reflects growing demand for personalised cancer care and the trust placed in us by our community. As the UK'S leading provider of personalised cancer care. we delivered compassionate support across a wide range of needs via our National Centre, digital, and community services. A key part of our reach came through our partnership with Genesiscare. As the lead provider of personalised support in their cenlres, Penny Brohn Cancer Care delivered over 9.700 appointments to people undergoing treatment, extending our model of care to thousands more across the UK. This collaboration refleds the strength of our approach and the power of partnership lo reach people when Ihey need us most. Like many charities, we faced financial pressures in 2024 bul responded with determination and focus. We grew commercial income, increased retail turnover, expanded venue hire, and continued to diversify revenue, demonslraling resilience and long-term ambition. As this report shows, 2024 was a year of slabilisalion and progress. We introduced new services like Personal Planning and Connect. strengthened our counselling and menopause support, and secured national accreditation for our health information. We improved referral pathways and laid foundations for a new online prehabililation service. In all of this, we kept evolving, making meaningful strides towards a more responsive and resilient future while staying true to OLJr aim of helping people feel more in control of their health and wellbeing during cancer. Looking ahead, we are sharpening our strategy and strengthening our identity. With a refreshed leadership team in place, we are focused on embedding Penny Brohn Cancer Care as a nationally respected, proudly Bristol-based brand-rooted in place, purpose. and the power of compassionate care. On behalf of the Board of Trustees, thank you to everyone who made this year possible. From our staff and volunteers to our supporters and partners.. your dedication continues to inspire. Together, we are building something lasting. Stephen Rosser Chair of Trustees
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Our Transfomiational Services In 2024, Penny Brohn Cancer Care set ambitious goals to expand our support services and reach more individuals affected by cancer, ensuring they have access lo the care they need to live well, regardless of their prognosis. Throughout the year, significant progress was made in increasing both the number of people supported and the breadth of services available. A key highlight was the 9°/0 increase in total clients, bringing the total number of individuals accessing in-person and group support to 2,137. Particularly encouraging was the 300/0 rise in new registrations, demonstrating that our outreach initiatives are successfully connecting with those in need. These efforts focused on making our services more accessible, relatable, and relevant, particularly through NHS and Macmillan referrals and targeted engagement with cancer support groups. Enhancing Accessibility and Diversity A major priority in 2024 was expanding access lo a more diverse range of people with cancer. While progress was made in engaging a broader audience, certain challenges remained. Efforts lo reach more men with our services were slower than anticipated, but valuable insights were gained that will inform future approaches. Similarly, our efforts lo support people from a wider range of socio-economic backgrounds saw mixed results. The proportion of clients from the least deprived areas (deciles 8-101 remained al 470/., the same as in 2020, while 120/0 of users came from the most deprived areas (deciles 1-31. Efforts lo improve ethnic diversity were also a focus, although data collection remains incomplete. Early indications suggest that 790/0 of new clients identified as While British (compared to the UK average of 700/91, while 89,/0 identified as White, representing a decrease from 930/0 in 2020. While these results show progress, increasing accessibility and engagement across diverse communities will remain a core priority in 2025 and beyond. Client Voice and Co-Production The Client Voice Group grew significantly in 2024, reaching 40 members-24 of whom joined this year. Clients have helped shape new services, including offerings for men and online resources. Two Client Voice newsletters were published by our volunteer Client Voice Lead and shared with our wider supporter base. Embedding client voice into service development remains a core principle of our approach. Tailored Support for Key Can¢er-Related Concerns Recognising that people with cancer share common holistic support needs, such as managing fatigue, anxiety, insomnia, and hormonal changes, we tailored our services to focus on practical, accessible solutions. This approach ensures our services remain both effective and widely beneficial, while also allowing for personalised pathway navigation for those with more specific needs. Several tsrgeled service packages were introduced in 2024.. Menopause Support: Following a successful pilot in 2023 with Genesiscare patients, we rolled out four online multi-expert group sessions, allended by 104 participants, and introduced a new Menopause Wellbeing Day. which saw 55 in-person allendees. Psychological Support: We expanded our counselling services with the launch of the Mind Matters Wellbeing Day, attracting 31 bookings and 25 allendees. Additionally, we introdu¢ed Connect, a series of counsellor-led emotional support groups tailored for both general cancer patients and those with advanced diagnoses. Although attendance was lower than expected Ilypically 3-6 participants per session), the service has been highly valued. and a full review is planned for 2025.
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNTS Personal Planning Seniice: This one-to-one navigation support was introduced in May 2024, offering 88 appointments. Feedback was overwhelmingly positive, with clients booking belween 2 and 10 follow-up services. One client remarked, "Just so in¢dible - Gombining professional and knowledgeable with empathy and support. Thank you.. Since launch, 1000/0 of Personal Planning clients have said the service helped them understand how Penny Brohn Cancer Care55 can support them. Evaluating Expanded In-Person Services With the generous support of Walk the Walk Worldwide, we were able lo expand our in-person services, providing a safe and uplifting environment for individLJals affected by cancer. In 2024, 417 people attended 12 themed Wellbeing Days and seven residential Living Well Retreats al our Bristol cenlre. Among these new offerings, our Mind Matters and Menopause Support Wellbeing Days proved particularly popular, attracting high levels of interest and being overbooked in some cases. Conversely, our efforts lo engage more men with our services through Men's Recharge Days proved more challenging, with lower attendance than anticipated. However, client feedback on these new Wellbeing Days was overwhelmingly positive, with an average satisfaction rating of 4.7 out of 5 across all sessions, reinforcing the need lo refine and develop these offerings over time. One participant from the Recharge Day for Men said, "Overall fantastic. Has tmly, positively chsnged the direction of my cancer journey for the better." Another attending the Menopause Wellbeing Day remarked, "A goodmix of theory andpractical experiences. Excellent lunch. I definilelyfeel topped up. Feedback from the Mind Matters Wellbeing Day was similarfy strong.. "Really lovelyday. Lols of content. Really enjoyed meeting people... Our Residential Retreats also maintained high satisfaction scores, with allendees rating the overall experience al 4.8 out of 5. One participant shared, -This retreat has saved my lrfe. All my emotional, spiritual andphysical needs have been met.. I will go home nurtur6d, restored and energised." Expanding and Evaluating Hybrid 1-1 and Group Services In 2024, we continued lo build our online services programme. offering over 20 live groups including Nutrition Know How, Yoga, Clinical Hypnotherapy, Lymphoedema Support, Menopause Support, and Connect (group counsellingl. A rolling ev8lu8tion programme, using follow-up surveys and validated prelpost measures, has consistently shown high satisfaction and pos((ive outcomes. In a 2024 survey, 750/y of respondents said the number of services was "about right,. and 730/0 rated the content as very helpful.. Ninety-five Pernt said they would recommend our online services lo others. Clients highlighted the accessibility of online services.. "I was very grateful to use this when I was al my lowest ebb in hospital.. the infom7ation and follow-ups wer8 so valuable."Anolher said, "Fatigue is a real Issu]01n1n9 groups online meant I could still participate while resting in bgd." Evaluation of our flagship online Treatment Support Programme showed a 4.8 out of 5 average satisfaction score. Eighly-one percent of participants said il helped them feel more confident about getting through treatment, and 1 OOOA said they would recommend it. One client reflected, °From the first session, I fell like I'd been gentlypicked up from the floorandsetstraight again... l am incrediblygrateful to have found Penny Brohn when I did.~ Our other one-trFone servi8 also continued lo achieve strong OLJtcomes. In 2024, 95 /0 of doctor one- to-one clients felt supported and listened to, and 98°/o said they would recommend the service. Among clients receiving nutritional therapy, 94 % fell empowered lo make informed choices, and 97.10 reported a better understanding of their dietary needs. One client noted, "I came away feeling like a person again rather than a cancerpatl8nt... I feel so empowered by the support I havg received from Penny BrohTr- 8nd yes, there are things I can do to keep myself well."
PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNT Prehabilitation and Symptom Management Understanding the importance of preparing individuals for cancer treatment, we began work on a prehabililalion service pilot towards the end of 2024. This initiative, led by our Physical Activity and Clinical Leads, in collaboration with our Nutrition Lead and oncology teams from the Bristol, North Somerset, and Gloucester IBNSSGI Integrative Care Board, is sel to launch in May 2025. The new Servi will provide a slruclured support package for individuals awaiting cancer treatment, helping them build resilience and improve outcomes. Additionally, we broadened our support for key physical and emotional side effects of cancer treatment, including expanding services for psychological support, menopause-related symptoms, lymphoedema, and scar concerns. Improving Infomiation Accessibility As part of our commitment lo providing high-qualily, evidence-based information, Penny Brohn Cancer Care a¢hieved Patient Information Forum IPIF Tickl a¢creditation in May 2024. This recognition underswred the trustworthiness and reliability of our health information. We have since launched rigorously reviewed resources.. Eating WellDuring Cancer Treatment and Eating When Eating Becomes Difficutt. Strengthening Healthcare Referrals and Outreach In 2024, Penny Brohn Cancer Care made significant strides in raising awareness and increasing referrals from healthcare professionals, cancer support charities, and patient groups. A particular highlight was our attendance al the Oncology Professional Care conference in May 2024. where our Lead Doctor, Dr Catherine Zollman showcased our Treatment Support Programme. This event generated substantial interest among Clinical Nurse Specialists in our integrative cancer care approach. Our outreach efforts have also translated into tangible improvements in referrals. 22 /0 of new clients were referred by their cancer nurse specialist in 2024, a marked increase from previous years. Additionally, 120/0 of new clients found us through Macmillan referrals, further reinforcing our growing visibility wf(hin the healthcare sector. In response lo community needs, we also expanded the range of support available in the Bristol area, introducing Nordic Walking groups, creative therapy sessions, a Community Kitchen for cooking demonstrations, a Nutrition Café, and Tea & Chal sessions. Additionally, we launched weekly massage and reflexology appointments at our Hub in the Bristol Triangle, providing further holistic support lo those undergoing treatment. Partnership with Genesiscare Penny Brohn Cancer Care's long-standing partnership with Genesiscare remained a cornerstone of our mission to deliver holistic, pers0n-ntred ¢an¢er Care. Now in its lenlh year, the collaboration ¢onlinu8s lo provide vital holistic support to P8opI8 receiving treatment al Genesiscare c8nlr8s across Ihe UK. Beeen December 2023 and November 2024, the partnership supported 2,849 patients, delivering over 9,700 appointments. Initial consullalions included 1,979 holistic needs assessments, 303 wellbeing appointments, and 68 palliative reviews. Following these, a wide range of therapies and support were delivered, including 2,689 sessions of reflexology, 716 of acupuncture, 718 counselling sessions, and 640 lifestyle support consultations. Clients also accessed 1,271 relaxation and mindfulness sessions, 81 relative support sessions, and 1,105 end-of-treatment reviews. Although overall patient numbers saw a small decrease of 6D/o compared to the previous year, this was attributed to temporary service changes due to staff sickness, vacancies, and the refurbishment of bmo Genesiscare centres. Despite this, the Servi continued lo deliver exceptional support, with patients
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT 1963 male and 1,886 female) accessing care across a wide range of needs. Breast cancer remained the most common diagnosis, with 1,226 patients receiving support. Feedback from patients has been overwhelmingly positive.. "Penny Brohn gives vrfal support al a difficult lime when there is nothing else in the medical trealmenl structure lo help. "I'm so bloody glad I came here, one of the best decisions I made... I'm coming out of this positivel~ In the latest Patient Experi8nc8 IPREMI data sel, 88Q/o of respondents In=4041 said the service made a positive difference lo their heah and wellbeing. The PROM data showed a 77QA clinically significant improvement in patients, primary concern. Continuous improvement was a key feature of the service throughout 2024. Developments included refining the induction and training process for new staff, strengthening remote counselling provision, and enhancing communication within the delivery team through weekly updates and monthly collaboration meetings. One key change was the recruitment of a core-hours counsellor to provide greater slabilty within the counselling team. In addition lo the clinical and wellbeing impact, the partnership also generated £13,799 through fundraising activities across the Genesiscare nehNork. To mark ten years of partnership, we created an infographic celebrating a decade of impact, featuring cumulative attendance and outcomes data. This was shared with Genesiscare colleagues and displayed in each cenlre. Brand and Marketing In 2024, Penny Brohn Cancer Care focused on strengthening our internal identity and external communications. A major strand of this work was the development of new organisational values. The process began in late 2023 with a staff workshop introducing the concept of values and exploring examples from across the sector. Staff worked in groups to reflect on what the charity s values should be, feeding back suggestions which were then reviewed and refined into a proposed sel. These proposed values were reviewed by the Senior Leadership Team and formally approved by the Board of Trustees in February 2024. A follow-up session in March reinlrcKluced the values lo staff, providing context for the work and encouraging teams lo reflect on how the values align with their own objectives and aspirations. The year also saw the launch of the Ham Green House webstte and social media channels (Facebook, Inslagram, and Linkedlnl, expanding the venue's reach and visibility. A new monthly newsletter for healthcare professionals was introduced, which grew to a subscriber base of around 160 contacts. The charity produced ils first-ever client case study video. capturing a powerful story lo help communicate the impact of its services. It also Irialled two Instagram Live sessions in collaboration with expert practitioners from partner organisations. Email marketing continued to grow, with the weekly services newsletter reaching an average of 700 more recipients compared to the previous year. Financial Sustainability Following the financial challenges of 2022, we embarked on a five-year financial recovery plan designed lo restore stability and build long-lerm sustainability. We have just completed th8 second year of that plan.
PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNT Year one of the plan Ilhe 2022123 financial yearl delivered a better-than-expected outcome, thanks in part to a combination of one-off legacies, the success of our Emergency Appeal, and significant growth in our hospitality income. These factors resulted in a nel surplus of £94,734-an encouraging early slep in our recovery journey. In the current financial year120231241, we concluded the year with a nel deficit of £336,310. This was primarily driven by underperformance in legacy income, coupled with slower-lhan-anticipaled momentum in our wider fundraising activity. In addition, while hospilalily income remained strong, il plateaued after the significant growth seen in the previous year and therefore did not offset shortfalls in other areas. While this year's financial result represents a setback, fluctuations are lo be expected and must be viewed in the broader context of our five-year recovery strategy. OLJf CLJrrent position, while in deficit, does not significantly deviate from the overall trajectory of the plan. We remain confident in our long- term strategy and are actively working to regain momentum in 2025 and 2026, with early indicators suggesting that this is achievable. The five-year plan continues lo provide a strong framework forfinancial decision-making, and we remain committed to disciplined financial management, strategic income diversification, and sustsinable growth across all areas of the charity. Income Generation In 2024, we were able to underpin our fundraising efforts with a diverse range of initiatives helping to secure essential income to support our seNices. Kicking off the new financial year, December 2023 saw our most successful Christmas Concert yet, raising £7,500 and welcoming over 400 guests for a festive evening of mLJSiC and celebration. We were privileged lo partner with Bailey of Bristol, who selected Penny Brohn Cancer Care as their Charity partner for 2024. Through a variety of creative fundraising initiatives, they raised an outstanding £16,167, significantly exceeding their original fundraising largel of £1,000. Another key partnership in 2024 was with the Bristol Property Agents Association IBPAA}, which raised over £20,000-funds expected lo be received in summer 2025. We were also honoured to be named Bristol Breakfast Rolary's Charity of the Year by Bernd Langheim, President of the Bristol Breakfast Rotary, which led to our selection as the main beneficiary of the Bristol Dragon Boat Race Festival 2024. Corporate teams took lo the waters of Bristol, securing sponsorships and rallying behind our cause. As a result, we received almost £9,000 from the event, and we are immensely grateful for their generosity and continued support. One of the year's key fundraising achievements was the launch of Penny Brohn Cancer Care's first- ever summer raffle in July and August 2024, which raised over £4,300. Our Autumn Matched Funding Appeal proved lo be another fundraising highlight, reaching an impressive lolal of £36,000 thanks to Ihe generosity of our donors and matched conlribulions. We also secured significant funding through grants and charitable foundations lo support our vital work. Notable support included.. Continued major backing from Walk the Walk Worfdwide, a key supporter of our work. A grant from the Tim Tiley Bursary Fund to help sustain our online servi¢es. A grant from the Gerald Micklem Charitable Trust lo support our nutrition programme. Ongoing annual support from the Medlock Charitable Trust. this time to resource our digital support groups. Funding from the Screwfix Foundation to carry out essential repairs to the roof in our garden room.
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT These income generation successes were instrumental in allowing us to continue providing life- changing services to those affected by cancer. We remain incredibly grateful lo all our corporate partners, individual donors, granl-giving organisations, and community fundraisers who have supported Penny Brohn Cancer Care throughout 2024. The National Centre al Ham Green House continued lo thrive as a Health & Wellness community, reinforcing its role as both a sanctuary for cancer clients and a dynamic space for like-minded organisalions. In addition to being a safe and tranquil haven for those affected by cancer, the National Centre has become a sought-after venue for away days, team-building events, and workshops, attracting a diverse range of synergistic groups and organisations. Operating seven days a week, the Hospitality team worked tirelessly to accommodate independerbt residential events and relreals, with most weekends fully booked throughout the year. This demand has resulted in a significant income stream of £500,000+ per year-encompassing sublets. extemal bookings, and ad hoc therapist sessions-and is now successfully covering the core operating costs of Ihe National Cenlre, in line with our strategic aim. To further enhance accessibility and visibility, Ham Green House now has its own venue hire website, allowing potential clients to explore the National Centre's offerings with ease. Since our last report, we have welcomed several new tenants, including Feel Better Bristol, specialists in Myofascial Release, and a Somatic Experiencing Iherapisl. These new additions complement our existing tenants, which include National Centre for Integrative Medicine INCIMI, SWEDA, Holistic Wellbeing, and several individual Iherapisls. The National Centre's largest external customer remained Internal Family Systems UK IIFSI, a renowned therapy training organisalion. Additionally, we frequently hosted NHS departments for team and training days, further strengthening our connections within the healthcare sector. Beyond the financial impact, the increased activity at the National Centre has raised awareness of Penny Brohn Cancer Care's mission, introduced new audiences to our work, and fostered potential future ambassadors and donors. By blending financial sustainability with our core purpose, Ham Green House continues to be an invaluable asset lo the charity- As part of our long-lem financial recovery plan, we granted a long lease on a portion of land adjacent to our National Centre to Natural Academy, a Bristol-based organisation that delivers nature-based and inlegralive training programmes in mental health, wellbeing, and leadership. This partnership not only contributes lo our income diversification and enhances our long-lerm sustsinability, but also represents another example of a tenancy agreement with a values-aligned organisation whose mission resonates strongly with Penny Brohn Cancer Care's holistic approach lo health and wellbeing. The Hub - our charity shop and wellbeing space in Clifton, Bristol continued to grow and thrive, achieving a record turnover in 2024. This upward trajectory reaffirms its value not only as a key source of potential unrestricted income bul also as 8 vital presence for Penny Brohn Cancer Care in the heart of the city where our roots began. Recognising this potential, we committed to extending the lease until 2030 (with no rent increase), ensuring we give the original concept- disrLJPted in its early years by the COVID-19 pandemic- the time il deserves to prove its impact. Beyond retail, the Hub is embedding itself further into the community. hosting events such as book signings with authors whose work aligns with our Whole Life Approach and Commitment lo diversity. Importantly, this year also saw the return of cancer clients to the Irealmenl rooms al the back of the Hub a significant slep towards realising our vision ofa space where income from the shop directly supports wellbeing ServIS on-site. 10
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Looking Ahead to 2025 Building on the achievements of 2024, Penny 8rohn Cancer Care remains committed to sustaining and enhancing our impact across all areas of the organisation. While the financial landspe continues lo present challenges, our focus for 2025 is on maintaining service quality, improving infraslruclure, and laying the foundations for future growth. Our key priorities for the year ahead include.. Developing a clarified organisational strategy, co-led by the CEO, Head of Services, and Head of Fundraising and Communications. This strategic framework will guide the charity beyond its recent survival phase and onto a trajectory of stability and growth. Strengthening our fundraising capacity through the development of a new Fundraising and Communications Strategy, led by our newly appointed Head of Fundraising and Communications. This strategy will align with broader organisational goals and ensure long- term income sustainability. Expanding one-to-one counselling services lo reduce waiting times and meet increasing demand. Launching our online prehabililation service, supporting individuals ahead of cancer treatment with accessible and tailored care. Updating our Health and Wellbeing Wheel, enhancing how clients identify and navigate the support most relevant lo them. Continuing our partnership with Genesiscare. with ongoing discussions underway to extend our service delivery agreement and build on ten years of successful collaboration. Growing our hospitslity business, with strong forward bookings already secured and ongoing discussions wfch two shared-purpose organisalions that may join our health and wellness community as new tenants. Enhancing our hospitality infrastructure, including the release and repurposing of additional space within the National Centre for commercial use. Work is currently being scoped and phased, with the first new operational rooms expected to be ready by April 2025. Exploring the potential lo grant a further lease on land adjacent lo our National Centre, building on previous arrangements as part of our strategy to diversify income and strengthen long-lerm financial sustainability. Implementing a new datsbase platform Ixviewl to streamline operations and improve servi Coordination, accessibility, and efficiency across both Services and Hospilalily. Expanding our volunteer engagement, with plans to bring on a volunteer lo support a review of internal documentation and processes, ensuring they align with current gocKI practice. In addition, Services has begun recruiting professional volunteers lo contribute their expertise and enhance delivery. As we move into 2025, our unwavering focus remains on ensuring that every individual facing cancer has access to the support they need to live well, while continuing to build a resilient, forward-looking organisalion. THANK YOU.. To everyone who trusts us lo be part of their journey, sharing their experiences and inspiring us every day we are truly grateful. To Walk the Walk Worldwide, for 25 years of unwavering support. Your funding partnership continues to power our services and our mission. To the Tim Tiley Bursary Fund, the Gerald Micklem Charitable Trust, and the Medlock Charitable Trust, whose loyal and generous support over many years has qLJielly bul powerfully helped sustain our resilience and underpin our progress. To Genesiscare, for ten years of partnership, collaboration, and shared commitment to person- cenlred cancer care. Your support helps us reach thousands of people with the compassionate, integrative care they deserve.
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNTS To Internal Family Systems UK, for their long-standing partnership and continued presence al the National Cenlre. Their support goes beyond room bookings-they've become true ambassadors for our work. To Cloud & More, for their generous donation of networking hardware, improving the reliability of phone and video communications for our counsellors and therapists. To Invictus Mechanical and the Warriors of Warmth, along with Straight Up Scaffolding, Hawk Installation, and BBS Plumbing and Heating Supplies, for wming together lo deliver a vital boiler replacement project, largely free of charge. To Clarke Willmotl, for providing pro bono leg81 support during our18nd transaction and the renewal of our lease on the Hub. We would additionally like to thank- The Screwfix Foundation, The Albert Hunt Trust, The Elizabeth And Prince Zaiger Trust, The February Foundation, The D'oyly Carte Charitable Trust, J and M Britton Charitable Trust, The Joyce Fletcher Charitable Trust, Abbvie UK, The Beaverbrook Foundation, The Frank Litchfield General Charitable Trust, The Hilary Awdry Charitsble Trust, The Lawson Trust, Axentis Michael Charitable Trust, The Waller Guinness Charitsble Trust, Maclaggart Third Fund, Lillie Johnson Charitable Trust, Mazars Charitable Trust, Nisbets in the Community, Renishaw Charities Committee, The Helianthus Charitable Trust, VWV Charitable Trust, The Gilander Foundation, The Ruth and Stuart Lipton Charitable Trust, Quartet Communtty Foundation, and Leanne & Winston Newman Charitable Trust. STRUCTURE. GOVERNANCE AND MANAGEMENT Penny Brohn Cancer Care is a registered charity trading as Penny Brohn UK and is also legally constituted as a company limited by guarantee. Established on 17 May 1982, the charity is governed by its Memorandum and Arbcles of Association, which define its purpose, slruclure, and operational framework. Govemance Penny Brohn Cancer Care is overseen by a Board of Trustees, whose primary role is to define the Charity's vision, strategy, and objectives in alignment with its charitable purpose. The Board is responsible for ensuring that the charity's financial resources are managed effectively and that all activities are conducted in a manner consistent with ils mission. In 2024, the Board convened four times in person and three limes remotely lo review progress and guide the organisation. To maintain comprehensive oversight, the Board operates through five dedicated sub-committees, each focusing on a core aspect of the charity.. Finance & Audit, Services, People, Culture & Inclusion, Fundraising & Marketing, and Commercial. These committees meet remotely. ensuring agile governance. In 2024, the Finance & Audit Committee mel six limes,. the Services Committee, Fundraising & Marketing Committee, and Commercial Committee each mel four times,. and the People, Culture & Inclusion Committee met three times. Trustee Appointment. Induction. and Training Trustees are appointed based on the skills and expertise required for strong governance al Penny Brohn Cancer Care. A formal recruilmenl process is in place to identify suitable candidates, ensuring they align with the organisalion's needs and values. Once appointed, each Trustee undergoes a comprehensive induction and training process, tailored to their individual background and experience. This includes access to key documents, a guided lour of the National Cenlre, introductions to the Chair, Executive Team, and key staff, and an overview of the roles, responsibilities, and obligations of being a Trustee. 12
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNTS Trustees are encouraged lo participate in internal and external development opportunities that enhance their ability lo fulfil their governance role effectively. A Trustee's term of office lasts three years, with the option lo serve up lo three consecutive terms. Extensions beyond this period are only granted in exceptional circumstances. All Trustees volunleer their lime and re1ve no financial compensation or benefits from the charity. They are required lo declare any conflicts of interest and musl withdraw from decision-making where conflicts arise. Details of any expenses reclaimed or related party transactions can be found in note 8 of the financial statements. Key Management The Board entrusts the day-to-day management of Penny Brohn Cancer Care to the Chief Executive Officer ICEOI, who is supported by a Senior Leadership Team. This team meets weekly to oversee operations and actively participates in Trustee sub-committee meetings related lo their areas of responsibility. Public Benefit The Trustees ensure that Penny Brohn Cancer Care continues lo deliver meaningful public benefit in line with its mission and objectives. In doing so, they adher8 lo the Charity Commission's guidance on Public Benefit under the Charities Act 2011. This commitment ensures that all activities are focused on supporting those affected by cancer in the most effective and impactful ways possible. Our Charltable Purpose As outlined in the Articles of Association, Penny Brohn Cancer Care's charitable purpose is lo advance health and well-being. as well as to alleviate sickness and distress, with a particular focus on supporting those affected by cancer. The Trustees retain discretion over how these objectives are best achieved, ensuring the charity remains adaptable to emerging needs. Pay Policy The CEO'S remuneration follows the same structured framework as that used for all employees and is governed by the Executive Pay Policy. This poliw is regularfy reviewed by the People, Culture & Inclusion sub-commillee, with oversight from the Trustee Board, to ensure fairness and alignment with Sector stsndards. Trading Subsidiary To support ils charitable work, Penny Brohn Cancer Care operates a wholly owned trading subsidiary, PB UK Commercial Ltd. This subsidiary generates revenue through commercial activities and donates all taxable profits via Gift Aid to the charity. PB UK Commercial Ltd is managed by a Board of Directors, which included two Trustees during the reporting year. The charity retains fLJII ownership of the subsidiary s share capital. Risk Management The Trustees have implemented a comprehensive risk management strategy to safeguard the charity's operations and long-lerm sustainability. This includes.. A formal risk policy, approved by the Board and subject lo annual review. A Strategic Risk Register, which identifies potential risks and outlines mitigation strategies. The register is reviewed regulady at Trustee meetings, with risks assessed based on impact and likelihood. A range of systems, policies, and procedures designed lo minimise potential disruptions and ensure the charity can respond effectively to emerging challenges. 13
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT By maintaining robust govemance and proactive risk management, Penny Brohn Cancer Care continues lo strengthen ils resilience, ensuring it can provide essential support lo people living with cancer now and in the future. Strategic Risk Register Penny Brohn Canr Care Tecognises that strategic risks have the potential to significantly impact the achievement of our core mission. These risks may arise from internal factors, such as financial sustainability or regulatory compliance, or be driven by external events that are beyond our control bul require a proactive response. To manage these risks effectively, we maintain a Strategic Risk Register, which enables us to identify, assess, and mitigate key threats lo our organisalion. This structured approach ensures that we remain resilient, adaptable, and well-prepared to navigate challenges while continuing to provide high-quality support to those affected by cancer. The key strategic risks identrfied for the organisation are.. Financial sustainability: Our long-term financial sustainability remains a core strategic risk. While we have Suc$$fullY diversified income streams in recent years, particularly through growth in hospitality and commercial activity, we continue lo carry exposure through our reliance on a small number of key funding and delivery partnerships. We are actively managing this risk through focused engagement with partners and by continuing to grow a broader base of income through fundraising, grant applications, and commercial diversification. Oversight is provided by our Fundraising & Marketing and Commercial SucomMittees, and financial planning is closely monitored by the Finance & Audit sub-¢ommittee. Rising costs: Like many organisations in our sector, we are facing continued cost pressures across energy, fty)d, and staffing. Increases to the National Living Wage and Employer National Insurance contributions will raise the overall cost of delivering our services in 2025. We are mitlgating this through ongoing value assessments, close budget scrLJtiny, and by exploring operational efficiencies wherever possible. IT infrastructure.. As our services evolve, so too do the digitsl and operational systems that underpin them. To meet the needs of our stsff, client, and hospilalily clients, we continue to assess and improve our IT infrastructure, including telephony, soare, and dats systems, to ensure they are secure, cost-effective, and fil for purpose. Each of these risks is actively monitored and managed through robust governance slruclures. including oversight from relevant sub-committees and continuous evaluation of our financial, operational, and strategic positioning. By maintaining a dynamic and responsive approach lo risk management. Penny Brohn Cancer Care ensures that we remain well-equipped to fulfil our mission while safeguarding the long-term suslainabilily of the charity. Fundraising Standards At Penny Brohn Canr Care, our work is made possible through the generosity and commitment of our supporters. We take this responsibility seriously and are dedicated lo ensuring that all fundraising activities are conducted ethically, transparenuy, and in line with best practice. We employ a diverse range of fundraising approaches lo maximise our impact and support our vision. These include di¢1 mail and email camp8igns, community and sponsored challenge events, and dedicated fundraising events. We also welcome legacy and in-memoriam donations. work closely with grant-giving trusts and foundations, and cullivale corporate partnerships to further our mission. As 8 registered member of the Fundraising Regulator, Penny Brohn Cancer Care adheres to the Code of Fundraising Practice, ensuring that our activities meet the highest standards of integrity and 14
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNTS accountability. Additionally, we are proud to be an organisational member of the Institute of Fundraising, further demonstrating our commitment lo excellence in fundraising. All fundraising efforts are managed directly by our in-house team, and we do not engage third-paty professional fundraisers or commercial participators lo solicit funds on our behalf. One exception is our fundraising lollery, which is licensed by North Somersel Council and administered externally through Unity Lottery (Sterling Management Centre Limiledl, a licensed External Lollery Manager IELMI regulated by the Gambling Commission. We ensure full compliance with all relevant codes and laws, including providing guidance on responsible gambling, self-exclusion options, and support for vulnerable individuals. Respect for our SUPFX)rters is at the heart of our approach. We are committed to ensuring that rbo one is subjected to undue pressure or persistent requests for donations. Every communication includes an option lo unsubscribe or opt out, allowing individuals to engage with us in a way that feels right for them. Above all, we prioritise compassion and ethical engagement, particularly when working with vulnerable individuals. We are pleased to report that in the past year, we have received no complaints regarding our fundraising activities, reflecting our dedication lo maintaining the highest standards of trust and accounlabilily. Staff In 2024, we saw an expansion of Penny Brohn Cancer Care's staff team with the introduction of several key roles aimed at enhancing service delivery and internal operations. Recognising the importance of collaboration, the charity implemented a Return to Office plan in October, designed lo bring teams together and strengthen cross-organisational working. To support this transition, a new communications plan was introduced as part of our hybrid working model, ensuring that staff remain connected and engaged. The Employee vol group continues lo meet quarterly, providing staff with a platform lo discuss current issues, share feedback, and raise questions directly with the Senior Leadership Team, CEO, and Trustees. Additionally, Penny Brohn Cancer Care has reinforced its commitment lo equity, diversity, and inclusion IED&I) by appointing two ED&1 Champions and training five staff members as Mental He8lth First Aiders, ensuring a more supportive and inclusive workplace. Volunteers Volunteers remain an essential part of Penny Brohn Cancer Care's workforce, contributing over 5,000 hours of their time throughout the year. Their dedication is evident across multiple areas of the charity, from maintaining the gardens al our National Centre to supporting retail operations al the Hub and assisting with fundraising events. Beyond these core roles, volunteer opportunities have continued to expand within client services, allowing more individuals lo conlribul8 directly lo the charity's mission. Penny Brohn Cancer Care also remains committed to fostering future generations, offering valuable work experience placements and supporting Duke of Edinburgh students, helping lo cullivale skills and experience in those looking to make 8 difference. Clinical Governance Ensuring the safely and quality of our client-f8cing services remains a lop priority al Penny Brohn Cancer Care. Our commitment to clinical governance spans all aspects of service delivery, including face-to-face, virtual, remote, and online resources. Through a robust quality assurance framework, we continuously evaluate and refine our services to uphold the highest standards of safely, care, fairness, leadership, and responsiveness. 15
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNTS Our clinical governance framework is designed to safeguard the well-being of our clients, ensuring that every individual accessing OLJr support receives the best and safest care possible. By maintaining a structured and proactive approach, we remain dedicated to delivering ServIS that are not only effective bul also aligned with Ihe evolving needs of those we support. FINANCIAL REVIEW Statement of Financial Activities {SoFAI In 2024, the Group generated £2.159m in unrestricted income {2023'. £2.38m} and £269,309 in reslricled income12023.' £379,561), leading to a total income of £2.429m12023'. £2.761 ml. Our principal sources of income for the year were.. Income Source Trusts and Grants Services and Partnershi Donations, Community and Cor orate Givin Legacies Retail & Hospitality Total 2024 (£'0001 248 20231£'0001 257 Strategic 894 868 578 587 53 656 2.429 380 669 2,761 Ongoing economic pressures have meant that despite the progress made in 2023, the charity was not able lo offset the general increase in costs by increases in fundraising income, resulting in a significant deficit. Our long-standing partnership with Genesiscare has remained a reliable contributor to our income base. We were again grateful for the support of charitable trusts and foundations, including a generous contribution of £100,000 from Walk the Walk, an enduring funder whose backing has enabled us to deliver our'Feel Better, package of care and provide practical support for people preparing to Ljndergo Chemo and radiotherapy and offset the side effects of their treatment. Balan¢9 Shogt The Group's nel assets redUd by £713,000. Current assets reduced by £92,000 as the increase in debtors of £84,000 was offset by a reduction in cash of £172,000. Creditors due within one year increased slightly as the charity drew down on a £200,000 credit banking facility. The mortgage on the National Centre continued lo be paid in line with expectations, resulting in a further reduction in long- term liabilities. Free reserves decreased by £152,000, bringing the year-end balance lo £122,000, while designated funds, including the value of land, reduced by £476,000 to £4.950m. There was a post balance sheet revaluation of the land and buildings, which redLJced the value by £377,000. Reslricled reserves also reduced by £85,000 and lotalled £159,000 at the end of the year. PB UK Commercial Ltd Our trading subsidiary, PB UK Commercial Ltd, continued to operate key income-generaling activities such as room hire and hospitality services al the National Cenlre, along with retail through The Hub and our online shop. In 2024, the subsidiary delivered a profil of £41,00 solid continuation of Ihe improvement seen in 2023, reflecting higher occupancy and retail footfall. 16
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Reserves Policy Penny Brohn Cancer Care aims lo maintain Free Reserves equivalent lo two months. payroll costs, which equates to approximately £327,000 for the 2024 financial year. Al year end, our free reserves stood at £122,000, which falls short of Ihis targel. However, Ihe charity's aim is to get increase free reserves lo this policy level as quickly as possible. This policy is reviewed annually and informed by projected income, liquidity needs, access to credit, and overall financial risk. The charity holds a £200,000 credit facility with Triodos Bank, offering vital flexibility in managing short-lerm cash flow. The National Centre was last revalued in May 2025 al £5.6m, with a remaining mortgage of approximately £885,000 al the end of 2024. Going Concern The Finance and Audit Committee continues lo monitor financial performance closely, including regular scrutiny of cash flow, income forecasting, and debt obligations. £200,000 of our creijil facility was drawn upon during the year and continues to aid cash flow stability. In light of current reserves, ongoing income diversification, and access lo secured borrowing, Ihe Trustees have reasonable confidence in the charily's ability to continue operating for al least 12 months beyond the date of this report. The going concern basis of accounting has therefore been applied in preparing the 2024 financial slalements. 17
PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Statement of trustees, responsibilities The trustees (who are also directors of Penny Brohn Cancer Care for the purposes of company lawl are responsible for preparing the Trustees, Report (incorporating the strategic report and directors, report) and the financial statements in accordance with applicable law and United Kingdom Accounting Stsndards, including Financial Reporting Standard 102.. The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Accepted Accounting Practice}. Company law requires the Iruslees lo prepare financial ststemenls for each financial year which give a true and fair view of the slate of affairs of the charitable company and the group and of the income and expenditure, of the charitable group for that period. In preparing these financial slatemenls. the Iruslees are required to- select suitable accounting policies and then apply them consistently., observe the methods and principles in the Charities SORP., make judgments and accounting estimates that are reasonable and prudent., slate whether applicable UK Accounting Standards have been followed, subject lo any material epartures disclosed and explained in the financial slalemenls- and prepare the financial slalements on the going concern basis unless it is inappropriate to presume that the charitable company and the group will continue in busin8SS. The Iruslees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. In so far as the trustees are aware.. there is no relevant audit information of which the charitable company's auditors are unaware., and the trustees have taken all steps that they ought to make themselves aware of that information. Approved by order of the members of the Board of Trustees and signed on their behalf by.. Stephen Rosser Chair of Trustees Dale.. 18 July 2025 18
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Independent auditor's report to the members of Penny Brohn Cancer Care Opinion We have audited the financial statements of Penny Brohn Cancer Care (the 'parenl charitable company'l for the year ended 30 November 2024 which comprise the Statement of Financial Aclivilies, the Balance Sheet, the Cash Flow Statement and notes to the financial slatemenls, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102.. The Financial Reporting Standard applicable in the UK and Republic of Ireland Iunited Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements.. give a true and fair view of the stste of the Group's and of the parent charitable company s affairs as al 30 November 2024 and of its income and expenditure for the year then ended., have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice., have been prepared in accordance with the requirements of the Companies Act 2006. Basis for opinion We conducted out audit in accordance with international Standards in Auditing IUKI IISAS IUKII and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant lo our audit of the financial statements in the UK, including the FRC'S Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Conclusions relating to going concern In auditing the financial slalements, we have concluded that the directors, use of the going concern basis of accounting in the preparation of the financial ststements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent charitable company s ability to continue as a going concern for a period of at least twelve months from when the financial statements are aulhorised for issue. Our responsibilities and the responsibilities of the directors with respect lo going concern are described in the relevant sections of this report. Other Informatlon The Iruslees are responsible for the other information. The other information comprises the information included in the annual report other than the financial slalemenls and our auditor's report Ihereon. Our opinion on the financial statements does not cover the other information and, except lo the exlenl otherwise explicitly slated in our report, we do not express any fomi of assurance conclusion thereon. In connection with our audit of the financial stalemenls, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstalemenls, we are required to determine whether there is a material misstatement in the financial statements or a material misstalemenl of the other information. If based, on the work we have performed, we conclude that there is a material misstatement of this other information. we are required to report the fact. We have nothing lo report in this regard. 19
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of the 8udit'. the information given in the trustees, report (incorporating the directors, report) for the financial year for which the financial statements are prepared is consistent with the financial statements., and the directors, report has been prepared in accordance with applicable law requirements. Matters on which we are required to report by exception In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors, report. We have nothing to report in respect of the following matters in relation lo which the Companies Act 2006 requires us lo report to you if. in our opinion: adequate accounting records have not been kept in the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us., the financial statements of the parent charitable company are not in agreement with the accounting records and returns., certain disclosures of trustees, remuneration specified by law are not made., or we have not obtained all the information and explanations necessary for the purposes of our audit., or Responslbllltles of trustees As explained more fully in the Iruslees, responsibilities statement, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstslemenl, whether due lo fraud or error. In preparing the financial slatemenls, the Iruslees are responsible for assessing the Group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, mallers related lo going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the Group or the parent charitsble company or to cease operations, or have no realistic allernalive but to do so. Auditor's responsibilities for the audit of the financial $tatgments Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due lo fraud or error, and lo issue an auditorfs report that includes our opinion. Reasonable assurance is a high level of assurance, bul is not a guarantee that an audit conducted in accordance with ISAS {UKI will always delecl a material misstatement when it exists. Misslalements can arise from fraud or error and are considered material if. individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows.. we identified the laws and regulations applicable lo the charity through discussions with those charged with governance and other management, and from our knowledge and experien of the sector- 20
PENNY BROHN CANCER CARE ANNUAL REPORT AND A OUNT we focused on specific laws and regulations which we considered may have a direct material effect on the financial slalements of the operations of the company, including the Companies Act 2006, laxalion legislation and data protection, anli-bribery, employment, pensions, environmental and health and safely legislation., and we assessed the exlenl of compliance with the laws and regulations identified above through making enquiries of management, inspecting legal correspondence and remaining alert during the audit for any indications of non-compliance. Our audit procedures in relation lo fraud included but were not limited to.. making enquiries of those charged with governance and other management as lo where they considered there was susceplibilily lo fraud, their knowledge of actual, suspected and alleged fraud., discussing amongst the engagement team the risks of fraud.. gaining an understanding of the intemal controls in place to miligale risks of fraud and non- compliance with laws and regulations., testing journal entries to identify unusual transactions., assessing whether judgements and assumptions made in determining the accounting estimates sel out in the accounting policies were indicative of potential bias,. and investigating the rationale behind significant or unusual transactions. There are inherent limitslions in our audit prOdureS described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non- compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to delecl than those that arise from error as they may involve deliberate concealment or collusion. A further description of our responsibilities for the audit of the financial slatemenls is located on the Financial Reporting Council's website al www.frc.or .uklauditorslaudit-assurance-ethicslauditors- res nsibilities-for-the-audit. This description forms part of our auditor's report. Use of our report This report is made solely to the parent charitable Company's members, as a body, in ac¢ordan¢e with Chapter 3 of Part 16 of the Companies A¢1 2006. Our audit work has been undertaken so that we might stale lo the parent charitable company's members those matters we are required to state in them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility lo anyone other than the parent charitable company s members as a body, for our audit work. for this report, or for the opinions we have formed. Joshua Kingston ACA (Senior Statutory Auditor) For and on behalf of Burton Sweet Limited Slatulory Auditor The Clock Tower 5 Farleigh Court Old Weston Road Fl8x Bourton Bristol BS48 1 UR Dale.. 18 July2025 21
PENNY BROHN CANCER CARE CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNTI YEAR ENDED 30 NOVEMBER 2024 Llnrestricted Funds Restricted Funds Total Funds 2024 Total Funds 2023 Income from.. Don81ions arwj leg8CleS charItsb activibes Other trading activities Investments Other income 598,914 5.450 655,911 440 11.3eAI 269.309 868,223 g05.450 65S,911 440 11,3eAI 1,213,809 876.120 658,621 376 9,725 Total income 2,159,351 269.309 2,428,660 2,760,651 Expenditur• on.. Raising funds charlb a¢uvMes 589,D27 1.821,694 589,027 2.175.943 618,019 2.047,462 354.249 Total expendlture 2.410.721 3Y.249 2.7.970 2.665.481 N10¥808 on invostmonts 14361 Net incomellexpenditurel forthe year 1251.3701 184,9401 1336,3101 94,734 Transfers between fund5 Loss on revaluation of fixed asset 1376.6291 1376.6291 Net movement in funds 1627.9991 184.9401 1712.9391 94,734 Total funds at the start of the year 5,699,569 244.330 5,943.899 5,849,165 Total funds at end of year 5.071,S70 159,390 5,230,960 5,943,899 The Group has no recognised gains or losses other than the results lor the year as set out above. All of the aGtivities of the Group are classed as continuing. See note 11 forlhe comparative Staternentof Financial Activities. The notes on pages 26 to 42 forni part of thv&e financlal statements. 22
PENNY BROHN CANCER CARE THE CHARITY'S STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNTI YEAR ENDED 30 NOVEMBER 2024 Llnrestricted Funds Restricted Funds Total Funds 2024 Total Funds 2023 Income from.. Don81ions arwj leg8CleS charItsb activibes Other trading activities Investments Other income 598,914 5.450 585,330 440 11.3eAI 269.309 868,223 g05.450 58S,330 440 11,3eAI 1.213,809 876.120 576,067 376 9,725 Total income 2,088,770 269.309 2,358,079 2,678,097 Expenditur• on.. Raising funds charlb a¢uvMes 559,D85 1.821,694 559,085 2.175.943 597,047 2.047,462 354.249 Total expendlture 2.380.779 3Y.249 2.735.028 2.644.509 N10¥808 on invostmonts 14 14361 Net incomellexpenditurel forthe year I292.9) 184,9401 1376,9491 33,152 Transfers between fund5 Loss on revaluation of fixed asset 1376.6291 1376.6291 Net movement in funds 1668.6381 184.9401 753.5781 33,152 Total funds at start of year Irestatedl 5,710,108 244,330 5,954.438 5,921,286 Total funds at end of year 5.041,470 159,390 5,200,860 5,954,438 The Charity has no recognised goins or SSeS other Ihan the results for the year as set out ave. All of the aGtivi118s of the charity are Glassed as continuing. See note 11 forlhe comparative Staternentof Financial Activities. The notes on pages 26 to 42 forni part of thv&e financlal statements. 23
PENNY BROHN CANCER CARE BALANCE SHEETS AS AT 30 NOVEMBER 2024 Company number.. 01635910 Group 2024 Charity 2024 Group 2023 Charity 2023 Fixed assets Intangibl8 assets TangiNe assets Investments 12 11,501 6.332.201 6,129 5.837.650 6,129 5.837.650 6.131 6.332.201 6,131 14 5,843,779 5,843,781 6,349,831 6,349,833 Current assets Stock D8biors Cash al bank and in hand 7,528 316,850 409.045 12.468 232.405 580.762 16 441.602 252.317 512,891 316.467 733.423 e93.919 825.635 829.358 credIr$.. amounts fallirvJ due within one year 17 1478.3281 1468.9261 1322.2671 1315.4531 Net Current assets 255.095 224.993 503.368 513.905 Total a88Ot8 le88 ¢urr6iit Ilabllltl88 6.098.874 6,068.774 6.853.199 6.863,738 Creditors." amounts falliry due after Tnore than one year 18 1867,9141 1867,9141 1909,3001 1909,3001 Net assets 5.230.960 5,200.860 5.943.899 5.9Y.438 FUNDS Restrieted funds Unrestricted funds Genar81 funds Designated funds lin¢ludirwJ rev81uation reserve of £4,529.87412023". £4,785,261) 23 159.390 159.390 244.330 244.330 121.627 4.949.943 91,527 4.949.943 273.687 5.425.882 284,226 5.425.882 23 Total unrestricted funds 5,071.570 5,041.470 5,699,569 5,710,108 Total funds 5,230,960 5,200.860 5,943.899 5,954,438 The Trustees acknowledge thr responsibililEs for complwng with the requirements of the Act wlh respe¢ttO acctirj records and yepar81ion of financial sla18ments. 18 July 2025 These financial statements were approv bythe Trustees on.............................................. and are signed their behalf by.. Stephen R05S8r Ch8ir of Trustees Tho not8$ on pallè8 26 to 42 fomi part of th financlal 8tstomot)ts. 24
PENNY BROHN CANCER CARE CONSOLIDATED STATEMENT OF CASH FLOWS YEAR ENDED 30 NOVEMBER 2024 2024 2023 Not Net cash inflowlloutllowl from operdting activities 19 1281,2151 398,016 NOnPtIonal cash flows= I¥tIng a¢tlvlllo8 Payments fortangible fixed assets Payments for iDiangible a$selS Proceeds from disposal of fixed assets Investment income 149,2421 178.7431 30.000 440 1.000 376 177.3671 Flnanclng actlvltl88 Loan repayments Loan advancement 171.6841 200,000 171.6831 128,316 171.6831 Net cash inflowllouttlowl forthe year 20 171,717 248,966 Cashflow Restrlctlons Charity law rxohibits the use of net C8sh infiows on any endowed or other reslricled lund lo oftsel nel Cash ouffiows 8nyfund outsKle its own objects, 8xcept on speGial authority. In practic8, this restriction has nDt had any effect on cash flows for th8 year. The notes on pages 26 to 42 forni part of these financial statements. 25
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 1 Accounting policies A¢¢ountlng conv•ntlon The financial statements have b8en prepared in accdanGe wth the historical costa)nvenlion lexceptwh8re oth8pNi8e slal8d in th8 accounting policy nolel and in accordance with the Ststemenl of Recommended Practice.. Accounting and Rewrknng by Charities preparing ir accounts in 8c¢trdanct wilh the Financial R8porting Standard applicab in Iht UK and Rtpublic of Ird8nd IFRS 1021 issu8d in October 2019. and Ihe Financial Reporbng Standard applicable in the United Kingdom and Republic of Ireland IFRS 1021, and the Companies Act 2006. The charity is a public benefit entity as defined under FRS102. Golng concem The Charilys forecasts and projections show that the Charity expects lo operate within the level of its current debl facility. As detsiled in the annual repDrt, thtr Chrity $trk$ to in¢rtase incomtr from fundr8iging 10 8n8ble morè peoplè to 8¢¢es$ fr&8 Support lu hdp Ihtrm livè wtrll with cancer. and allow us to Influen the heahhcare agenda. Th& Fin8n¢8 and Audit Commlll8& r•gu18rfy revi v8ri0u$ rel•v¥nl report8 from the Ch8ri1y. including for8¢8s1 ¢a8h flow scenarios, 10 attasi positively lo Ihe Charitys going concern slalus. This review is shared with the full Trustee Board al each Trustee meeting. The Charily h8s iwo committed working capilal1oan facilities. 11 plans to continue lo hold these term debt facilities, secured on the Natnl CeDtre, th31 are used lo bridg8 tiTning gaps ID revenue raising. The Charity received a £50.000 BDunce Back103n in DeceTnb8r 2020, this loan has a full1100%1 government-backed guarantee againstthe balan of the facility. repayments of this loan commenced In December 2021. In Aprll 2025 Iha charity ¢onvaried a £200k Revolving Credit F8¢ilily thai w8s in pla¢$ al the end of the 2024 fin8naal ar Snio a fiv8- yeartemi ban. In addition lo these, the Charity holds a 10 year mortgage which expires in 2029. The Truskes have a slru¢lured approach lo the financial slrakgy of the Charity. which Induded the 5 year pl8n reviewed byTruslees annuallyfrotn which the 12 month budget and cashfknw foreGaSt 15 preparEA. Quarterly forecasts are also preparEA. TtU51ees review and monitor the budgets and ¢ashfjow$ 81 each Trustees meeting. inlerr(galing vari8nce$. This ¢onlinuous monitoring 8nd wnlrol ensure the Tslee8 are abl£ lo properly review th£ Charity's going COnGem Status and ils finanGial viabilty. The Trustses review th8 Charitys forecast and projections al each Board meeting and have a reasonable expectation that the Charity has adequate resources to continue In operational 8Aisi8n¢8 for a ptriod of ai It8$1 12 monihs folk)wing thè dai• of 8pprov¥l of Ih8sa financial È1818mtntÈ. Tht Group th8r•fo ¢oniinu88 10 adopt the going conr bas for preparing Ils cons(Aidated financial statements. Basls of eonsolldatlon The ConsoliE18tsd Slalement of Finan¢i81 ActiltIeS ISOFAI, C801181e0 Babnce Sheet and ¢ons(rfidaled C8sh Flow Slalemenl consoliQ8ie the financial slal8ments of the Charity and its Subsidiary, PB UK CornmerGial Ltd. The results of the subsidiary are consolida18d on a line by line basis. crftScal a¢¢ountlng ludg8m8llt8 and key Sources of ostlmatlon un¢8rtalnty In the application of the charitys accounting policies. which are described In this note. Trustees are required lo make judgements, eslimales and 8ssumpbons about Iht C8rrying valu6s of assets and liabilities thai ar6 not adIlY appartni from Othèr sour¢ès. Tht tÈlimaies and underlying a5sumplK)ns are based on historical erien and other factors Ihatare considered relevanL Actual resu115 maydrffer from Ihese esum81e$. The eslimale$ 8nd underlying assumplh)ns are revEwed on an woing b8sis. Revisions lo accounting estimaks 8re re¢conised in the perd in which th8 8slimate is revised rfth8 affects onlythal p8ri(MJ or in the period of the revisi( and firtur8 periods rf th8 revision affects the current and future perdS In the view of the Trustees, no assumptnS ConrnIng Ihe fulure or estimation unrtalntyaffeC1lng assets aThJ liabilities at the balance sheet dale are Ilkely lo wull In a makri81 adiuslmeni to Iheir ¢arrwng 8mounLS In the next Iinan¢l¥l year. The prin¢ip818¢wunling pollcies adopkd, judgements and key sources of estirnation uncertainty in the presentation of Ihe financial stateTnents are outlined in the following paragraphs. 26
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 1 Accounting policies Icontinuedl In¢omo Income from donatnS is included in income when these a re1vab. except as follows.. l. Wh8n dorbors sp8crfy thatdalIon8 givtrn to the charity musi b8 us8d in futtjrtr accounting P8riod8, th8 incomtr is défétred until thosa Perd5.. 11. When domrs impose conditions which have to be fulfilled before Ihe charity becomes entitled to use such income. Ihe income is deferred Jnlil the pre-conditions have been mel. Legocie5 are included on o receivable basis where the charity is enlided lo Ihe income. it can be measured reliably and receipt is tKobable. Where leg*¢i6s have been notified to the charity. or the ¢h8rity 1$ ¥w8re of Ihe gr8niing of probait. and the criteria for Income recoynlln have not been mel. then the legacy is not included in income but is Irealed as a contingent asset and disclosed rf material. Investment income Is Induded on 8 reTriv8ble b851S. Exp8ndhur Expenditure is r8cognised onc8 there is a legal or conslTuclive obligation ID transfer economic b8nefil lo a third party, il is probable that transfer of econom benefits will be required In selllement and the amount of the oblwalion can be measured reliably. Expenditure Is c18gsified by activity. Tht ¢o$i$ of 88¢h activity m8d6 up of ihè total of direct costs and $har8d costs. including suppori costs invofved in undertaking each activity. Direct costs attributable lo a single activity are allocated direcuyto that activity. Shared costs which contribute to more Ihan one 8¢1ivily and tsupport ¢o$ts which 8re not aiifibul8ble to 8 single ¥¢bvily 8¢ 8PPOrfioned between those 8¢livilies on ¥ ba$ consislentwilh the use of the resources. Central staff costs are alkncated on the basis of time SFent. and depreciation Gharges alloGated on e portson of the asset's use. Expenditure includes Bllributable VATwhieh cannot be recovered. Ra181ng funds R81sing funds expenditu in¢lude8 those Costs Incurred in seeking voluntary conlribuiions, costs of gcK)ds sdd 8nd other cost8 whith include Ihe costs of nning and participating in fundraising events and collections and cost of goods purchased for resale. Charitable Activities Expenditure on charitable 8¢1ivilies Comprises those Costs ineurred by Ihe Ch8fity In the delivery of 11$ 8¢1ivilies and Servi$. It inckndes both osls that can be allocated directly lo this activity and those costs of an indirect nature necessary la support them. Support costs and other costs that cannot be direcdy attributed lo activities are alkncated on a basis consislentwith the use of the resource. Governan¢e ¢o$ts Governan costs include those costs associated with meeting the conslilulional and statutory requirements of the charity and include the audit fees and Costs linked lo the sir8legi¢ m¥n8gemenl of the charity. Governance costs are Induded within support costs. Pènsion Go8t$ and other pOstetIrement benefits The charily Coniribuies 10 defined tributIOn pension schemes. Contributions p8yable to the charit8 pension 8¢hemes are ¢h8r9ed 10 the Statement of Financial Activitses the peritM4 to which they relate. Intanglble assets IntsDgible ass81s CDsling £500 or rnore are capitalised and recognised when future economiG b8nefftE ar8 probable and the cost or value of Ihe asset can be measured rdiably. Intangible assets are initially recognised at cost sS accumulated amortisalion and impairment. AmortIsaln is calculated so 35 lowrite off tre 81 of an ¥ssel, less Ils eslimaled ullimsle residual value, overlhe useful life of th81 asset 8s follows.. Computér $oftw8r6 20'k straight linè basis 27
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 1 Accounting policies Icontinuedl Tanglbl8 fix assots Freehold buiklings are Included al v8lu¥lion based on open marf(el vtlu¥lion. Valuations tre pthrmed every five yetrs. All other tsngiNe fixed assets are inGlud8d at Gost less accumulated depreciation. Tangible fLYed assets costing £500 or mor8 are capitalised and recognis8d when future economic benefits are probable and the cost or value of the asset can be measured reliably. The Trustees of the charity catry out an annual Impairment rewew of the properties. DepreGiation is calculated lo write off the cost orvalualion of tangiblefixed assets, 55 its estimated uthmate re5Ual value, over the useful life of Ih¥l 8s$el as folbws. Frtehold prop8rty Long-lerm leasehold pr(perty Fixtures arbd fittings Computer equipment 2% Sirai9hl lint on buildings, no dfrpreu8in charyed on L8nd b8sed upon the length of the lease 5 to 10 years straight line basis 3 10 5 years siraighl Line basis Inve5ttnerbt property Thrj land and buildirbgs that constitu18 th8 National Centr8 of Penny Brohn CarbGer Care form a mixed us8 property where dem8nls of th8 propety are used for charitable purposes and elements are let or used commercially. As the Investment property elements are not separaNe and Ihtr fair valut cannot be m8*sur&d reliably, the tniiré proptrty 1$ acmunled for 8$ proptrtywlhin tan9iblt red a$strts. Fixed asset investment5 Fixed asset Investments ?re a form of fin8n¢i81 instrument and are Inits8lly re¢ogni$ed 81 Iheir Ir8nsa¢lion cosl ¥nd subsequently measured al fairvalu8 al the BalarbGe Sheet date. unles5 the valu8 Gannot be Tneasured reliably in which case il is measured al cost less impairm8nL Investment gain$ 8nd loss, whether reale or unrealised are combined and recognised a$ 8 gain or loss investments In the SOFA. Investments in subsidiaries and associates are included at cost less impairment at 30 November in the charitys accounts. Stock stocks ar$ valu6d 81 Iha lower of cost 8nd net rtra11s8bla v8lua, after maklng due allov4an¢& for obsolala and slow moving itèms. Cost includes all direct costs and an appropriate proportion of fix and Variable overheads. Donated items are not valued in stock and are rewgnised in income ontywhen sold. Cash and cash equlvaltnts C8sh ¥t b¥nk and cesh in hend In¢luLles Cash and short term highly liquid investments with a short mtlurity of three month$ or less from the da18 of acquisition oropening of the deposit or sitnilaraccounl. Financial instruments Tht ¢h8rty has tle¢16d 10 apply thé provisions of S8ction 11 '6asic Financial In$irumèni$' and S8ction 12'0th•r Fin8ntri81 In8trumtnts Issues, of FRS 102 to all of its financial inslrumenls. Financial instruments are recognised when the charity become5 patyto the contractual provIsnS of the instruTnenl. Financial asse15 and Iiabiliiies are offsei. with Ihe nel amounts presented in the financial slalemenls, when ihere is ¥ legally enforceable right lo sel olf the re(nISed amounts and there is an intention 10 5&tt1e on a net basis or to realise the a5sel and settle th8 liatwlity Simultaneously. Basic financial assets. whiGh include trade and other r8C8ivables and cash and bank balanGes. are initially measured at transaction price including transaction costs and are subsequendy carried al amortised cost using the effective interest rneth unless the arrangement constilul8s 8 fin8nciw transaction. where th8 financial ¥8È&t 1$ measured at tha pr888ni v8lu8 of th& futu r8C8ipls discountsd ai 8 m8rk81 rate of interest. Basic financial liabilitiès. including trade and othèr payables, and loans from group und&rt8king$, arè initially r6¢0gni8ad al transaction pri¢8 unless the arrangement conslitules a financing tronsactn, where the debt instrument is measured atthe present value of the fulure paymanls dlscounted ai 8 m8rk$l rale of Inte$1. 28
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 1 Accounting policies Icontinuedl Fund ac¢ountlng General funds are unrestricted funds which ore available for use al the discretion of Ihe Trustees in furtheronce of the general objectives of Charfly and which hava not been dasnated for otrtsr purposes. Designated funds cornprise unrestricted funds that have been sel aside bythe Trustees for particular purposes. The aim and use of each designaied fund is sel out in the notes the finanty81 stslemenls. Restricted funds can only be used for parbcular reStrted purFK)ses within the objects of Ihe charity. Restrictions arise when specrfied bythe donor or whtrn funds raised for parb¢ul8r restricted pJrposas. The costs of ralsing and adminlslerlng $u¢h funds 8r8 charged against the specffic fund. Furiher explanabon of the nature and purpose of each fund is Included in the notes lo Ihe fin8ncio1 statements. Invesimeni income. g81ns and losses are allocaied Lo the appropr181e fund. 2 Income from donations and legacies Group & Charlty Unrostsictèd Funds R8stridod Funds Total Fund8 2024 Genèral don81ion$ Donations from regular givers Legacies 469.124 76.514 53,276 269.309 738,433 76.514 53,276 Total for Group & Charity 598,914 269,309 868,223 Prior year Unrestricted Funds Restricted Funds Total Funds 2023 General donations Donations from regular glvfrrs Donations to purchase land Legacies 538.123 63.076 206.150 744.273 63,076 26.411 380,049 26.411 147,000 233,049 Total for Group & Charity 834,248 379,561 1.213,809 3 Income from charitable activities Group & ¢harlty Unrestricted Funds Restricted Funds Total Funds 2024 Total Funds 2023 Sèrvicé ntrated in¢om• from par[shIpS Other service generated income Catering income 894.303 894,303 834,462 33.607 10,061 11,035 11.035 $05,450 905,450 878,120 AJI income reWed forcharilable aclnfilies in the prr year was unrestricted. 29
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 4 Income from othertrading activities Unrnstrl¢tgd Fund5 Rèstrl¢t8 Fund5 Totsl Fun(J$ 2024 Total Fund$ 2023 Trading income.. Facilities inGome The Hub PB UK Comrneraal- management charges 88,152 108,372 388.806 88,152 108.372 388,806 61,903 100,408 413,766 Totsl ¢h8rfty 585.330 585.330 576.067 PB UK Commercial income Interroup activity 459,387 1388,8061 459.387 I388.8} 496,310 1413.7561 Total Group 655.911 655.911 658.621 JI Income re¢eNed forolher Ir8ding 8clivilies in the prior year was unreslrided. 5 Expenditurè on raising fund8 Current year Total Funds 2024 Total Funds 2023 The Hub Fundraising support costs 128,924 430.161 116,979 480.068 Totsl Charity 5S9,085 597,047 PB UK Commercial- management charges PB UK Commerci81 Olhtr trading tIP8ns8S Interroup activty 388.806 29,942 1388.8061 413,756 20,972 1413.7561 Total Group 589.027 618.019 6 Exp8ndltur8 on charftablo actIvleS Support Costs INote 71 Dlre¢t Costs Totsl Funds 2024 Group & Charity Online services In-personlgroup services One lo one sfrrvicss Partnerships 93.452 57.311 266.844 701.616 330,314 64.934 39,822 185.415 206.719 229,516 158.386 97,133 452.259 8,335 559,830 Group & ¢h¥rilytOtsl$ 1,449.537 726.406 2.175,943 30
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 6 Expenditure on charitable activf(ies Icontinuedl Support Cost$ (Note 71 Prlor year Dlr8¢t Costs Totsl Fun(J$ 2023 Online services In persoTrl group serwces One lo one servi¢e$ Partnerships 168.056 24,937 184.499 704,311 269.845 86.513 12,837 .978 362,572 138,914 2.569 37,774 279,477 1,066,883 408,759 Group & ¢harilyt0181s 1,351.648 695,814 2.047,462 7 Support costs Support costs are allocated between raising funds and Charitab activthes on the basis of staff time. Support costs. Included in notes 5 & 6. are as folbws.. Current &r Fundraisiny and publicty Charftable Activitie5 Total 2024 Stsff costs Olhercosls Office costs Building costs Finance costs Governance costs 277.813 69.062 21,972 49,689 6.514 224.691 502.504 69,062 153.609 349,015 46,477 35.900 131.637 299.326 39,963 30.789 Group & charilytolds 430.161 726.406 1.156.567 Prlor y88r Fundralslng and publicty Chaiitable Activities Total 2023 Staff costs Other costs Office wsts Building D35ts Finance ¢osis Governan costs 310.496 73,917 28,955 53.162 6.654 6.884 210.426 520,922 73,917 175.882 322,923 40,421 41.817 146.927 269.761 33.767 34.933 Group & charitytotas 480.068 695.814 1,175,882 8 Not Incom{8xp$nd6turSl for th8 year This Is $18lad after charging.. Group Char 2024 2023 2024 2023 Auditorfs remunerabo) for Stslutory audil seivi¢es for accounts preparation 13.060 4.090 12.150 3.800 9.480 2.475 8.800 2.300 Tslee3. r8mun8ralion Trustees. travel. meeting and training expenses- ne[2023.. 1 Irusteel Amorhsation Depre¢i81ion 64 17,271 99,081 17,271 99.081 111.896 111.896 Donations trom Trustees and related parties ¥mounted to £73412023.. £1.7201. 31
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 9 Staff costs and numbers The 8ggreg8le p8yrdl costs were.. Group har 2024 2023 2024 20rJ Wages & salarEs SoGial security costs Pension contributions Redundancy payments 1.735.274 134,756 81,338 1.667.778 130,139 78.774 9,368 1.735.274 134,756 81.338 1.667.778 130,139 78,774 9,368 1,951,368 1,886.059 1,951,368 1,886,059 The average weekly number of empbyees (including senior managemenmeadership tearnl during the year was.. Group Charty 2024 2023 2024 2023 Staff 109 106 109 106 The number of empbyees whose ernployee benefits lexcludirwJ e0Ye[ nSn costs) eXeded £60,000 was.. Group Char 2024 2023 2024 2023 £60.WO-£69,999 £70.(M)0- £79.999 Key management personnel The lolal employee benefts of the key manageTnent personnel for the year w35 £86,96612023.. t80,3061. 10 Taxotlon The charity is eAempl from Corporation tax on ils Charitable a¢Uvilles. 32
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 11 Statement of Financial ACtitieS comparative figure5 Group Forthe yearended 30 November 2023 UnrostsS¢tgd Funds R8strl¢to Funds Total Fun(J$ 2023 Income from.. Donations and legaGies 834,248 878.120 658.621 376 9,725 379,S61 1,213,809 878.120 658,621 376 9.725 Other trading actilieS Inve$itDents Other Income Total income 2,381,090 379.561 2,760,651 Expendlture on= Raising fund5 Charitable act51$ 618.019 1,802.000 618.019 2.047.482 245.482 Total oxpondthr• 2,420.019 245.462 2.665.481 Net losses on investments 14361 Net incornellexpenditurel for the year 139.3651 134.OQY 94.734 Transfers belw&n funds 148.4541 48.454 Net movement between fijnds 187.8191 182.553 .734 Totsl funds at start of year 5.787.388 61.777 5.849.165 Total fund5 at end of year 5,699,569 244,330 5,943,899 Charity Forthe yearerbded 30 November 2023 Llnrestricted Funds Restricted Funds Total Funds 2023 Income from.. Donations and lÉgacits 834.248 878.120 576.067 376 Y,725 379.561 1.213,809 878.120 576.067 376 Y.725 Other trading acliwlies Invtsim&nts Other Income Total incorne 2,298.536 379,561 2,678,097 Expenditure on= Raising funds 597,047 1,802.000 597.047 2.047.462 245.462 Total expendiiure 2,399.047 245.462 2,644,509 Net10sse$ on Investments 14361 Not In¢omo118xpgndfjtursl for th8 yoar 1100.9471 1Y.099 33.152 Transfers beiween funds 148.4YI 48.454 Not movemont botwo•n 182.553 33.152 Totsl fund8 at Start of year 5.859.509 61.777 5.921.286 Total funds at end of year 5,710.108 244.330 5.OM.438 33
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 12 Intangible assets Comput8r Softwaro Group and ¢h8rfty Totsl Cost At 1 December 2023 Additions 86.360 16 86.360 16 AI 30 Novambtr 2024 86,376 86,376 Amortisation Al 1 Dectmber 2023 Charge for the year 74.859 74,859 At 30 November 2024 86.376 86.376 Not Book Value AI 30 Novémbtr 2024 AI 30 November 2023 13 Tangible fixed as5et5 Long-t8m) leasehold property Freehold property Flxtures and littings Computer equlprrnI Group and charity Total Cost orvaluation Al 1 Dectmber 2023 Additions Disposals Rev8luallon 6.754.337 117,589 2.900 120.297 43.280 13,5521 65.382 3.062 13,8051 7.057,605 49.242 161,0651 11.060.629) 153,7081 11.060.6291 AI 30 November 2024 5.640.000 120.489 160.025 FA.639 5.985.153 Dtrprè¢iation Al 1 December 2023 Charge for the year Eliminaitd on disposal lrnpairmenl on revaluation 612.000 72.000 47.197 12,025 35.681 17.157 11.9921 30.326 10.714 13.8051 725.404 111,896 15.7971 1684,0001 1684.0001 At 30 November 2024 59.222 51,046 37.235 147,503 Not book valuo AI 30 Nov•mb&r 2024 5.640.000 61,267 108.979 27.404 5.837,650 AI 30 November 2023 6.142.337 70,392 84.416 35.056 6.332,201 It is Penny Brohn Cancer Care's policyto revaluefr&hold prOty every 5 years. The freehold property was revalued in May 2025 by Lambért Smiih Hampion. a firm of valutrs •K16rnal to th& Charily. The prc4)8rts opan m8rk81 valut was ¢onsid•rtd to b8 £5,640.(M)O In accordance with the RICS valuation model. Thtr historical cost of Ihtr ravalued freahold propèrty ass81s amounts 10 £1.110,12612023". £1.356,3761.
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 14 Fixed asset investment5 Grou Charty 2024 2023 2024 2023 Listed investments Al 1 December 2023 Unrealised gainl Ilossl Unlisted inve5trnents Investment in Subsl8rY 6,129 6.565 14361 6.129 6,565 14361 6.129 6.129 fj.131 6.131 Sharas in 9roup undertaking8 8nd p8rtiUP81ing inierasts. Subsidiary Undertakings Total Cost Al 1 Dectmber 2023 and ai 30 Novwnb8r 2024 Details of undertakings= Country ol In¢orporatlon Proportfjon of Votlng rlghls and 8har88 held 2024 2023 Company name Holdlng PB UK Commerty81 Ltd England and W81es Ordinary 100% 100% Principal a¢tivitlO8 Other retail sale of new gOS in specialised stores Other retail Sale not in stores, sta115 or markets Other a0mmOd8on PB UK Commercial Ltd Yearended Yearended 30 Nov 2024 30 Nov 2023 Turnov8r Cost ol sales 459,387 1403.7651 4,309 1427.3621 Gr088 prof 55.622 68.947 Administrative expenses 114,9831 17,3631 Operating profit 40,639 61,584 Interest pay8bk ¥nd simibr ¢h8rges Profit b6for6 taxation 40.639 61,584 Tax charge for the year Profitfor the pertod 40.639 61.584 Retained earnings brought fory*ard 110,5371 Retalned eamlngs carrled forwar 10.537 35
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 15 Stock Grou Charty 2024 2023 2024 2023 Finished goods and goods for resale 7.528 12.468 16 Debtors Group Charty 2024 2023 2024 2023 Trade debtors Amounts owtd by yroup urKJertakiTrJ8 Other debtors Prepayments and accru8d income 96,433 105.112 87,960 133,225 20.370 200.047 76,334 309,459 1.450 12S,648 20.370 2W.047 1,645 12S.648 316,850 232.405 441,602 512,891 17 Creditors.. amounts falling due wthin one year Grou Charty 2024 2023 2024 2023 Bank loans Other loans Trad8 creditors Amounts owed by group undertskityJs Other taxaln and s(Kial security Olhercredilors Accru¥ls tnd deferred InMe 31.160 210.225 85,334 30.114 Y,973 114.617 31.160 210.225 84.784 30,114 Y.973 114,012 75.455 22,347 53.807 74,431 27,903 65.229 75.455 22,047 45.255 74.342 27,603 59.409 478.328 322.267 468.926 315.453 Loan tsalibes al the yaar end aro wlh NalW&sl Bank and Triodos Bank, Secured on the freahold proparty oftha Charity. Deferred incorne Group Charty 2024 2023 2024 2023 Al 1 December 2023 Amounts released trom previous peri(rtls Resources defer in the period 10.597 110,5971 20.716 8,744 18.7441 10.597 10,597 110.5971 20.716 7,S73 17.5731 10.597 At 30 November 2024 20.716 10,597 20,716 10,S97 18 Creditors.. amounts falling due after one year Group Charty 2024 2023 2024 2023 Bank loans Other loans 856,547 11.367 887.706 21.594 8,$47 11.367 887,706 21.594 867.914 009.300 867.914 009.300 Loan facilthes al the year end are wlh NalW8sI Bank and Triodos 8ank, secured on the freehold property of the Charity.
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 19 Reconciliation of net movement in funds to net cash inflow from operating activities Group 2024 2023 si8iemeni of Financial A¢tivlti&S'. N61 movament in funds Loss on investments Loan interest Investment income Loss on disposal of fLKed asset Amorbsaiio Depwi81ion Increase in operational creditors.. current liabilities Decr88s6 in optraiional d•biorÈ Decrease in stock 1336,3101 94,734 436 24,824 13761 3,793 17,271 99.081 40,834 111,453 5.966 31,S96 14401 5,268 111.896 145,2371 164.4451 4.940 Net cash Inflowlloutflowl from operatlng actfvltle5 281.215 398.016 20 Analysl$ of Changes It) ¢ash durlng tho year 2024 2023 Change Cash at bank and in hand 409.045 580,762 171,717 2023 2022 Change Cash at bank and in hand 580.762 331.706 248.966 21 Anafy5i5 of Ghanges in net debt Current year At1Dee 2023 Operatlng cash flow5 Investlng rash flows Flnanclng cash flows At 30 Nov 2024 Cash al bank and in hand Debt due within one year Debl dLE after more th8n one year 580.762 140.0871 1909,3tK)I 1281.2151 128.316 1201.2981 41.386 409,045 241.3851 1867.9141 Tol81 368.625 281,215 18.818 31.596 700,2 37
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 22 Movement in funds At1D8¢ 2023 IncomA and galns Expgndf(ure 8nd10$so5 At 30 Nov 2024 Fortho yoor ¥nde(J 30 November 2024 Yran$tsr$ R•$trlct8d funds Bristol Whole Life Approach in Scouand Library Lymphoedema Nutritio OlhersTn811 donat5 Penny Brohn on the Hvjh Street Regnal donations 11.288 7,293 119.714 111.2881 16,9291 165.6521 116,0001 15001 364 54,062 15.000 soo 10.035 10.035 3,000 13.0001 2.275 2,275 3.000 21,960 22.478 16,667 Remote SeNi¢es Treatment Support Walk the Walk Walk the Walk F881 Better Package Counselling IT Garden Room Roof enopause Residential Retreats & Wellbeing Days Music & Arts Nicola Corey Fund 61.400 21.960 158.4001 93.725 171.2471 183.3331 127.5001 11,8661 13.9361 4.9981 10D.000 27.500 1,866 15.000 10.198 3,427 3,000 6.458 11,064 5.200 3,427 2,400 6.458 ieooi 244.330 269.309 354.249 159.300 Unrestricted funds Designated funds Capital fund including revaluation reserve G8n8r81 fund 5,425,882 284.226 1536,2321 12,221.1761 60,293 160.2931 4,949.943 91,527 2.088,770 5.710,108 2.088,770 2,757.408 5.041,470 Totsl funds Charlty 5.954.438 2.358,079 3.111.657 5.200,860 PB UK Commertil Ltd Internlity transactions 110.5371 459,387 1388.8061 1418.7481 388,806 30,102 10.539 29.942 30.100 Total fund5 Group 5.943,809 2,428.660 3,141,599 5,230.960 38
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 22 Movement in funds Icontinuedl Fortho yoor ¥nd8(J 30 November 2023 At1D8¢ 2022 At 31b Nov 2023 Income Expenditure Tran51ers Restricted funds Bristol Whole Life Approach in Scouand Homeopaihr ylol Library Residential R81reats & Wellbeiny Days Lymphoedem¥ Nutrition Ont 10 On• Other small donatnS Penny Brohn on the High Street Region81 donations Relaxation chairs Remote ServiGes Twlmenl Support Walk the Walk Land fund 11.288 9.000 8,500 12.580 22.652 11,288 19.0001 11,2071 112.5801 150.1381 115.2501 7.293 147.000 15.250 458 119.714 2.704 230 51,297 141,2621 11.8001 12.6201 149,1001 12.8381 166,2751 1D,035 1,800 4.895 11,000 2.296 2,275 38,100 542 150.000 26,411 93.725 174.8651 48.454 61.777 379,561 245.462 48,454 244,330 Unrestricted funds Desi9Traled funds C¥pilal fund including revaluation reserve General fund 5,398.728 460.781 1141.17fj1 12,258.3071 168.330 1216.7841 5.425.882 2,228 2,298,536 5,859.S09 2,298,536 12,399,483> 48.4541 5,710.108 Total fund5 Charity 5,921,286 2.678,097 2,644,94S 5,954,438 PB UK Commercial Ltd Inter-enlity transactions 496,310 1413,7561 1434.7281 413,756 110,5371 72.121 82,554 20.972 10.539 Total funds Group 5.849.165 2.760.651 2.665.917 5.943.899 Rèstritd fund$ Bristol Whole Lile Approach in Scotland The Bristol Whole Lrfe Approach in Scotland was a pilot projectto work in partnership with Dumfries Hous8 in Ayrshire, giving us the chance to lake our Bristol Vlhole Life Approach lo those living with cancer in Scoll8nd. Hom8OPathi¢ pilot A grant was received from Nelsons lo run 8 Homeopathy project with Ihe N81ional Centre for Integr81ive MedicirE INCIMI providing Individual consultations lo Penny Brohn UK Clients. Library Following the -purp0S1ng of thi5 grant in 2023, we recruited a parttime information and resource officer with the balance of the fund tIng sed lo pay for 8n associate to support the relevant work. Rtrsldtntlal Rotrtrats & Wtllbolng Day¥ Funds had been received in prior years to support those attending our in-person retreats and wdlbeing days. Lymphoodoma A rostriclad 16gacy w8s recwved lo make special facilities available to Ihosa lniS sufferlw Yth Lwrphoedèm8. A Iwnphoedam8 workshq) takes place each month led by a specialist lymphoedema practi1ner. 39
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 22 Movement in funds Icontinuedl NuttIOn Gerald Micklem Chgritable Trust supportthe S8ry costs of our llLrtrition lead who is responsible for leading and managirvJ the development and delfvery of Safe. affectiva. hlgh qualilyonline arvj In-parson nulrillon services. One to One Funds were received in November 2022 from The W8instock Fund and in 2023 frDm The Ann8ti Trustfor Onfrlo-one's th an ini8grallve doctor. Other small donatlons A donation had been received in 2022 to cover the cost of Tnovement exercise this arnount has been fully spent in the prioryear. A donation of £500 was received from Quartèt Community Foundation resirided 10 th6 PUrthas& of kitchèn 8ouipm&nt. Penny Brohn on the High Street Rtslricled funds had been retré1v from th8 Ntrwby Charit8bl8 Trugi to providtr Psychological servicès 81 Thtr Hub. This fètr&io-f8¢tr s8rwc8 provision was dela due Covid restrictions Reglon81 donatSons A donation was received from J & M Brit Charitable Trust for use in Bristol area. Relaxation chairs The relaxation Chairs find is 8 grant lo en8b us lo upgrade and repl8ce our rel8X81ion chairs. Rtrmtsta Sorvi¢68 We Gonlinu8 to provide our prograTnme of onlirbe 5UPPOrt Ihroughoutlhe y8arwlh natnal reach for peop18 affeGt8d by cancer, continualty reviewing and adapbng our offering. These funds have enabled us lo grow this seTrice and embed Il as part of our hybrid Servi model. Grants have been recerrfed frotn The Tim Ti18y Bursary Fund, Th8 Hdianlhus Charit8b18 T$1, Th8 WeinstoGk Fund. The HiL¥ry Awdry Charitable Trust, The February Foundation 3nd The Medlock Charitable Trust. Tr8atmont Support Our online Treatment SuppDrt Programme was supported by a grantfrom The Annet charitab Trust. Walk thè Walk A grantwas reiVed from Walk the Walk in 2023 to support and grown our in-person serveS On again through specialist Wellbeing days and ra8id$niial wlraals. Land furbd Fund restricted lo the purchase of ¥dj8ceni land lo the Nabonal Centre and 8880¢ialed Costs. The iransfer in the prior year represents the spend above restricted income, made frorn general fund5. Do8lgn81od funds Capltal lund and r8valuatlon r88orv The Capital fund repwsenis lh8 nel book value of18ngibl$ and InlangiNe flxed assets. lass loans secured on the relavanl assets. The revaluation reserve totals £4,529.87412023." £4,78S.2611 al the year-8nd. Walk the Walk Feel Better Package A grant was reiVed from Walk the Walk to prO¥e a'Feel Betterf support package building on of ourflagship Treatment Support Programme the furhds enabled us lo develop.'how-to' resources, online group sessions and specialist wellbeing days. Counselling Support was received from the N8wbyTrusl Ltd to SUPPDrt Durcoun8811ing programTne through the fundin9 of a counsellor whowould offers on&lo4)ne counselling. and facilitating an emotional support group. The Albert Hunt Trust and Abbvie UK provided grants to support our one- ttrone ¢ouns611ing $8s8lon8. IT Funds were provided lo enable us to purch8se three new bplops. 40
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 22 Movement in funds Icontinuedl Gardèn Room Roof Donations were tnade byThe Screwfix Foundation and The Will Charitable Trust for repairs lo Our Garden Ro(xn roof. Menopause A grantwas received from Siad lo provide specialist menopause sessions, Wellbeing days and reSoUrS for those clients experiencing earlyon$el menopause 8s a result of Ih¥r c8n¢er Ire8lments. Residential Retreats & Wellbeing Da Funds had been received from D,0eY Carte for 8 Wdlbeing D8y tsking 4¢e in December 2024. Mu81¢ & Arts Funds We received The Joyce Fletcher Charitae Trusi lo fund our weekly 8rt sesslons and support speclallsl muslc and 8rt wellbeing days. Nicola Corey Fund Bursaries are aVailae lo support parents with a child under the age of 16 to support with the support of childcare, transport or accommodation al our National Cenlre, where the p8reni hes a cancer diagnosis. 23 Analysls ot net osset$ between funds Charlty As at 30 November 2024 Unre8trictod Deslgnated General Fund5 Funds Restricted Funds Total 2024 Tangible fixed assets Fixed asset invesknents Current assets Creditors due within one year Creditors over one ¥r 5,837,650 5,837.650 6,131 5Y.529 1437,7661 111.3671 159.390 693,919 1468,9261 1867,9141 131,1601 1856.Y71 Total charlty 159.390 4,949.943 91.527 5.200,860 A8 at 30 November 2023 Unrestricted Doslgnated General Funds Funds Ro8trl¢ted Fund5 Total 2023 Tangible fixed assets Intangible fixed assets Fixed ¥$$el Invt$imenl$ Current assets Creditor5 due within on8 year Creditors over one year 6.332.201 6.332.201 6.131 585.028 1285.3391 121.5941 6,131 829,358 1315,4531 1909,3001 244.330 1887.7061 Totsl Charlty 244.330 5,425.882 284.226 5.9Y.438 41
PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2024 23 Analy515 of net assets between funds Icontinuedl Group A5 at 30 November 2024 Unrèstrl¢tsd Designated General Funds Funds Restricted Funds Total 2024 Tangible fixed assets Intsngible fixed assets Fixed asset Investments Current 8SS@IS Creditors due Wilhin one year Creditors over one year 5,837.650 5,837,650 6,129 574,033 1447.1681 111.3671 6.129 733,423 1478.3281 1867,9141 159,390 1856.5471 Total Group 159,390 4,949,943 121,627 5,230,960 As at 30 November 2023 Unrestricted Designated General Funds Funds Restricted Funds Total 2023 Tangibl8 fix8d assetg Intsngible fixe(l assets Fixed asset investsnents Current 8ss&ls Creditors due within one yegr Creditor5 over on8 year 6.332.201 6.332,201 6.129 581.305 1202.1531 121.5941 6,129 825,635 1322.2671 909,3001 244.330 1887,7061 Totsi Group 244,330 5,425.882 273,687 5.943,899 24 Operating lease commitments At 30 November 2024 the company had commilTn8nts to make future minimum ase payments under norFCarKel1ab operaling18ases as follows.. 2024 2023 Amounts payabl•'. Within one year Within two and five year Wlthin over five years 44.094 168,000 10.500 44.513 170,094 52.500 222.594 267.107 25 Rolat8d partlè8 Trustees are able lo make use of the accommodation al the National Centre when attending on business aThl usually provide a donation in respect of this. No Trustees were provided 8ny nights trmoall0 In the year12023'. Nlll. There are no transactnS wlh trustee5 orolher related parties olher than those disclosed a5 required bythe SORP elsewhe in the financKal slalemenls. 26 P08t balance sh8ot évont In J8nu8ry2025 the charity was nolthe(l of 8 legacy which Is estimated to be In the regi(x) of £230.000.These funds are expected lo be received in the 2025 financial yèar. 42